In an era defined by globalization and connectivity, expanding a business beyond borders promises a world of opportunities and is more than just selling products or services; it's adapting, innovating, and staying ahead in a landscape of diverse cultures, regulations, and consumer preferences. Gaining knowledge...
CBD – A Consumer Health Revolution Amidst Regulatory Ambiguity CBD (cannabidiol), one of many cannabinoids derived from the plant Cannabis sativa L. (cannabis) has gained enormous popularity over the last decade. While positive consumer perception of CBD continues to rise around the world, research suggests that...
CBD - Transparency & Regulation for Consumer Safety CBD (cannabidiol), one of many cannabinoids derived from the plant Cannabis sativa L. (cannabis), has gained great popularity among consumers in recent years. The exponential growth of CBD in all consumer product categories might be taken to suggest...
Manufacturer of pharmaceutical-grade CBD products to meet global Cannabinoid demand
Studies have demonstrated CBD’s proficiency to treat inflammation with the ability to remedy a number of physical and mental illnesses. Compounds with anti-inflammatory properties are highly prized in both wellness and medical markets, and CBD has the added benefits of antibacterial and antiviral attributes. With the popularity of tinctures, topicals and capsules promoting increased consumer accessibility and adoption, the global CBD market is expected to surpass $13 billion in revenue by 2028. The EU cosmetic ingredient database determined that cannabinoids can be used in cleansers and conditioners, with hemp-based CBD oil particularly revered as it rejuvenates damaged skin.
Colorado-based CBD-hemp extraction company Vantage Hemp Co. announced today it is in the process of achieving compliance with European novel food regulations regarding the distribution of pharmaceutical grade CBD extracts.